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ABSTRACT
Chronic exposure to arsenic compounds is one of the major public-health problems in many developing 
and some developed countries. The aim of this study was to investigate the effects of chronic exposure to 
arsenic on dermatological lesions, hypertension, and chromosomal abnormalities among people in a com-
munity in the northwest of Iran. The occurrence of dermatological lesions, hypertension, and chromo-
somal abnormalities was investigated in two groups: Ghopuz village, including 101 subjects with chronic 
exposure to arsenic in drinking-water and Mayan village, including 107 subjects with no exposure. Daily/
yearly absorbed amounts of arsenic were calculated for all subjects. Cumulative arsenic index for each 
individual was then estimated on the basis of age, water consumption, and location of residence. Arsenic 
concentration in drinking-water sources in Ghopuz and Mayan villages was 1031±1103 µg/L and non-
detectable respectively. The mean systolic blood pressure in the exposure group [n=137, 95% confidence 
interval (CI 132-142)] was significantly higher than that in the control group (n=107, 95% CI 99.9-114). 
A similar significant difference was observed for diastolic blood pressure (exposed: n=82, 95% CI 79-85 vs 
non-exposed: n=71, 95% CI 66-75). The incidence of hyperkeratosis was 34 times higher among the ex-
posure group compared to the control subjects [odds ratio (OR)=34, p<0.001)]. A significant difference was 
also observed in the occurrence of skin-pigmentation between the two groups (OR=2.4, p<0.007). Location 
and severity of the pigmentations were statistically different between the two groups. Twenty-five percent 
of the subjects in the exposure group showed chromosomal abnormalities (p=0.05). Arsenic exposure was a 
serious health problem in the region. More studies are needed to investigate the long-term effects and dose-
response relationship of arsenic in the region and similar areas. Wide-ranging monitoring programmes for 
drinking-water sources should be implemented by public-health authorities. 
Key words: Arsenic; Cross-sectional studies; Dermatological lesions; Hypertension; Chromosomal abnor-
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INTRODUCTION
Arsenic is a hazardous, naturally-occurring element 
widely distributed in the crust of the earth. Inor-
ganic forms of arsenic (pentavalent and trivalent 
forms) can be found in small amounts in the atmos-
phere, groundwater, and surface-water. Exposure to 
arsenic compounds is a major concern to public 
health in both developing and developed countries 
(1,2). Arsenic is an ingredient of a wide variety of 
products in manufacturing industries, i.e. wood 
preservatives, herbicides, insecticides, pesticides, 
fungicides, high-emitting diodes, semi-conductors, 
etc., thus making workplaces a source of inhalation 
of, and dermal exposure to, arsenic. Arsenical drugs 
have also been used for treating some medical con-
ditions (3,4). However, the main source of high 
exposure of general population to arsenic com-
pounds is water. Arsenic in drinking-water above 
the accepted standards demonstrated in many 
countries is a global problem affecting countries on 
all five continents (5). In some countries of Asia, 
the issue of chronic arsenic intoxication seems to Dastgiri S et al. Illnesses from chronic arsenic exposure in Iran
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be a more important public-health problem than 
in other regions of the world (6). In Asia, arsenic 
has been reported in groundwater in Bangladesh, 
Cambodia, China (including provinces of Taiwan 
and Inner Mongolia), India, Iran, Japan, Myanmar, 
Nepal, Pakistan, Thailand, and Viet Nam (5). The 
most serious damage to health has taken place in 
Bangladesh and West Bengal, India (5,7).  
In Iran, naturally-occurring arsenic is responsible 
for contamination in drinking-water. Kurdistan, a 
western province of the country, is having a major 
problem of arsenic contamination (8,9). 
A recent study in the villages of Hashtrud county, 
in the northwest of the country, showed that ar-
senic exists in the drinking-water at a higher level 
(10) than the World Health Organization (WHO) 
guideline value of 10 µg/L (11) and the national Ira-
nian standard value of 50 µg/L (12) in a quarter of 
the villages in this area. 
The acute toxicity of arsenic at high concentrations 
has been known about for centuries. A strong ad-
verse effect of low arsenic concentrations was re-
cently discovered to be associated with long-term 
exposure. Drinking-water is now recognized as the 
major source of human intake of arsenic in its most 
toxic (inorganic) forms (5). 
A number of studies have been reported to assess 
the effects of arsenic-contaminated food (13) and 
water in those communities with high level of con-
tamination (13-18). 
The disease symptoms caused by chronic arsenic 
ingestion are called arsenicosis and develop when 
arsenic-contaminated water is consumed for sev-
eral years (5).
Although some adverse effects on health have been 
reported for chronic arsenic exposure, it varies by 
different population groups, age, gender, cumula-
tive dose of arsenic, nutritional status, genetic fac-
tors, lifestyle, individual susceptibility, and differ-
ent chemical forms of arsenic in drinking-water 
(19-22). 
Many studies have been reported on the relation-
ship of chronic arsenic exposure with cardiovascu-
lar diseases (23-24), cerebrovascular events (25,26), 
hypertension and peripheral vascular disorders (27-
32), Blackfoot disease (33), carcinogenic effects (34-
43), diabetes (44,45), some neurological diseases 
(46-47), skin disorders (48-50), and chromosomal 
abnormalities (51-56). 
The first visible symptoms caused by exposure to 
low arsenic concentrations in drinking-water are 
abnormal black-brown skin-pigmentation known 
as melanosis and hardening of palms and soles 
known as keratosis. If the exposure continues, skin-
depigmentation is started, resulting in white spots 
that look like raindrops (medically described as 
leukomelanosis). Palms and soles further thicken 
and painful cracks emerge. These symptoms are 
described as hyperkeratosis and can lead on to skin 
cancer (57). 
The aim of this study was to investigate the effects 
of chronic exposure to arsenic on dermatological 
lesions, hypertension, and chromosomal abnor-
malities in a region in the northwest of Iran.
MATERIALS AND METHODS
Setting and subjects
East Azerbaijan province is located in the northwest 
of Iran with a cool and dry climate (Fig.) that cov-
ers an area of approximately 47,830 sq km. It has 
a population of around four million. The province 
has common borders with the current Republics of 
Azerbaijan, Armenia, and Nakhchivan (58). This 
cross-sectional study was carried out in Ghopuz vil-
lage (chronically exposed to arsenic) and Mayan 
village (control group). Both the villages are located 
in the East Azerbaijan province. 
Selected villages were similar, considering the eth-
nic, cultural background, and other socioeconomic 
factors. In Ghopuz, occupation of all people was 
agriculture. However, in Mayan, there were other 
occupations along side agriculture because of less 
distance to Tabriz (capital city of the province).
In Ghopuz, all people aged six years and more 
were included as exposure group (total number Dastgiri S et al. Illnesses from chronic arsenic exposure in Iran
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of subjects was 101—48 male and 53 female). The 
reason for selecting subjects aged ≥6 years was the 
status of exposure: exposure of subjects had been 
removed by local water and wastewater authorities 
since five years before our study. In the meantime, 
those people aged ≥5 years were allowed to have at 
least one year of exposure to arsenic in their drink-
ing-water. We, therefore, included everyone aged ≥6 
years for this study. This means that every subject 
(aged ≥6 years) in our study had at least one year of 
exposure to arsenic. For further uniformity, same 
criteria were considered in the control village. The 
control group was selected from Mayan with no ar-
senic in drinking-water as the main selection factor. 
A random-sampling method was applied, and 107 
subjects (41 male and 66 female) were selected as a 
control group. During the study, fortunately all the 
selected subjects had good cooperation with the re-
search team, and the refusal rate was zero. Physical 
examination was carried out in the premise of the 
village’s alderman in Ghopuz and in the govern-
mental health facility in Mayan. Before physical ex-
amination, verbal consent of the participants was 
obtained. Table 1 presents the characteristics of the 
study subjects. 
Sampling and analysis of water
There were three springs and a polyethylene reser-
voir as drinking-water sources in Ghopuz village. 
Water of one spring was used via the water-distribu-
tion network. However, in Mayan, well-water was 
available via the distribution network as the only 
water source. Water samples were collected in plas-
tic bottles cleaned with nitric acid and distilled wa-
ter. Two following sets of samples were collected: 
The first sample was used in measuring the com-
mon parameters, including cations (Ca2+, Mg2+, 
Na+, K+), anions (HCO3
-, SO4
2-, Cl-), total dissolved 
solids (TDS), electrical conductivity (EC), hardness, 
alkalinity, and pH according to the Standard Meth-
ods for the Examination of Water and Wastewater 
(20th edition, 1998) (59). 
The second sample was used in assessing heavy 
metal concentration (As, Se, Cd, Cr, Pb, Fe, Mn) in 
drinking-water using inductively-coupled plasma 
(ICP) method after acidification with nitric acid. 
Concentration of detection limits for each of the 
above elements was 70, 75, 6, 10, 64, 10, and 2 µg/L 
respectively. Quality control of analysis was carried 
out using standard solutions and plotting standard 
calibration curve before analysis of water samples.
To achieve a mean annual concentration of arsenic 
in drinking-water sources, we focused on measure-
ment of arsenic in the sampling programme. So, 
measurement of arsenic was continued for one 
year. The results of quality analysis of drinking-wa-
ter sources in Ghopuz during the past years were 
also collected. A structured questionnaire was used 
for collecting information on the type of water 
source, history of consumption, and changes over 
time. 
Definition and measurement of outcomes
Three sets of outcomes were measured, including 
prevalence of dermatological lesions (hyperkerato-
sis and pigmentation abnormalities), hypertension, 
and chromosomal abnormalities. 
Exposure to arsenic was defined as consumption 
of drinking-water with arsenic concentration more 
than 50 µg/L for at least one year. Individuals with 
residency less than one year in the village were ex-
cluded from the study.
Unexposed individuals were defined as those sub-
jects who consumed arsenic through drinking-
water with a concentration of 50 µg/L or less. 
After obtaining an informed consent from the par-
ticipants, a specialist physician performed physical 
and clinical examinations. During the study, the 
physician was aware of exposure status. To provide 
a more accurate diagnosis for the skin lesions, the 
physicians on the research team referred to the 
guidelines published by the United Nations (60) 
Table 1. Characteristics of study subjects: comparison between Ghopuz and Mayan
Factors assessed 
Ghopuz Mayan
Mean (SD) 95% CI Mean (SD) 95% CI
CAI (g) 14.7 (10.9) 12.1-17.3 0 (0) 0
Age (years) 33.8 (16.1) 29.9-37.6 29.6 (17.9) 25.9-33.1
Residence (year) 29.7 (15.3) 26.1-33.4 28.9 (17.9) 25.3-32.5
BMI (kg/m2) 23.6 (4.5) 22.5-24.7 22.5 (5.8) 21.3-23.7
Systolic blood pressure (mmHg) 137 (20.2) 132-142 107 (34.9) 99.9-114
Diastolic blood pressure (mmHg) 82 (11.5) 79-85 71 (22.1) 66-75
BMI=Body mass index; CAI=Cumulative arsenic index; CI=Confidence interval; SD=Standard deviationDastgiri S et al. Illnesses from chronic arsenic exposure in Iran
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and pictures available on web sources before the 
start of the study. During the physical examina-
tions and after measurement of height and weight, 
a physician interviewed each participant for the 
presence of skin-lesions, discomfort, and other 
diseases, if any, followed by auscultation and ob-
servation of the degree of skin-hyperpigmentation, 
hyperkeratosis, and the severity of each lesion cov-
ering the body-surface. A questionnaire was filled 
for each individual during face-to-face interviews. 
The questionnaire contained information on age, 
height, weight, blood pressure, skin-lesions and 
its severity, location and history of these lesions, 
smoking, residence, and family history. We did not 
gather educational information and housing con-
dition of the participants. Blood pressure of each 
participant was determined once in sitting position 
after at least 10 minutes of resting using a sphygmo 
portable-grade Richter manometer. Body mass in-
dex (BMI) was determined as an indicator of mal-
nutrition status. 
Cumulative arsenic index (CAI) was calculated for 
all the subjects (9). Lifetime dose of arsenic for each 
individual was then estimated on the basis of age, 
arsenic concentration of water sources, and loca-
tion of residence using the following formula:
CAI=∑di × AIAi 
AIAi=Ci × 1 g/1,000 mg × LPCD× 365 days/year 
Where: 
CAI  is  the  total  lifetime  intake  of  arsenic 
from drinking-water (g),
di is the duration of the ith water source used by 
each individual (in year),
AIAi  is  the  annual  intake  of  arsenic  through 
consumed water in the form of water or tea (g/
year), 
Ci is the mean annual concentration of arsenic 
in drinking-water (mg/L)
LPCD (litre per capita per day) is the volume 
of drinking-water consumed by each individ-
ual in the form of water or tea (L/day).
Chromosomal analysis 
We investigated the occurrence of chromosomal 
abnormalities in subjects with chronic exposure 
to arsenic in drinking-water (from Ghopuz) and a 
matched control group with no exposure to arsenic 
(from Mayan). For chromosomal analysis, periphe-
ral blood samples were assessed by micro-culture 
method (Difco Laboratory method), Gimsa stain-
ing, and G-banding of chromosomes. Chromo-
somal analysis was blinded.
Statistical analysis
Descriptive statistics (including proportions, means, 
and standard deviations), 95% confidence inter-
vals, chi-square test, and odds ratios were used for 
statistical analysis of data. The p value of ≤0.05 was 
considered significant. The SPSS software (version 
10.0) was used for statistical analysis.
RESULTS
Table 2 presents the results of analysis of water in 
the exposure group and control group. In the ex-
posure group, the hardness of water was almost in 
the range of ‘hard to very hard’, and pH of water 
was more than 7. A remarkable finding in the ex-
posure group was high amounts of nitrate in drink-
ing-water samples taken from no-piped springs in 
the village (about three times more than the stand-
ard level). The results of analysis of samples from 
Table 2. Characteristics of drinking-water in   
              Ghopuz and Mayan  
Characteristics of 
drinking-water
Ghopuz
(Exposure 
group)
Mayan
(Control 
group)
Electrical 
conductivity (µs/cm) 1,044.8 701
pH 8.24 8.3
Total dissolved solid 
(mg/L) 689.8 463
Phenol alkalinity 
(mg/L as CaCO3) 2.5 0
Methyl alkalinity 
(mg/L as CaCO3) 300 185
Total hardness (mg/
L as CaCO3) 362.5 210
Calcium (mg/L) 92.5 44
Magnesium (mg/L) 31.5 24
Sodium (mg/L) 88.9 75
Potassium (mg/L) 6.5 3.6
Chloride (mg/L) 54.9 78
Sulphate (mg/L) 83.9 70.6
Nitrite (mg/L) 0.033 0
Nitrate (mg/L) 111.6 8.5
Iron (mg/L)  0.0465 0.102
Manganese (mg/L) 0.001 0.002
Cadmium (mg/L) 0 0
Arsenic (mg/L) 1.031* 0
Selenium (mg/L)  0.0075 0.007
Chromium (mg/L) 0 0
Lead (mg/L)  0 0
*Mean of 4 drinking-water sources during one     
 year of measurementsDastgiri S et al. Illnesses from chronic arsenic exposure in Iran
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Mayan also showed the presence of minerals in wa-
ter, indicating the hardness of water in the control 
group.
Arsenic contamination was detected in water 
sources of the exposed subjects. Analyses of other 
elements showed a slightly higher concentration of 
selenium in the exposure group. In the water sam-
ples from Mayan (control group), we did not find 
any amount of arsenic. Interestingly, there was no 
high amount of manganese, along with arsenic. 
General characteristics of the study subjects are pre-
sented in Table 1. No significant effect was observed 
for cigarette-smoking (p=0.55). The mean systolic 
blood pressure in Ghopuz (n=137, 95% CI 132-
142) was significantly higher than from the con-
trol subjects (n=107, 95% CI 99.9-114). The same 
difference was observed for diastolic blood pressure 
(Ghopuz: n=82, 95% CI 79-85; Mayan: n=71, 95% 
CI 66-75).
Table 3 shows a comparison of dermatological le-
sions and chromosomal abnormalities in the ex-
posure group and control group. The incidence of 
hyperkeratosis was 34 times higher among the ex-
posed individuals compared to those in the control 
group (OR=34, p<0.001). The same difference was 
found in the location and severity of the lesions. 
Palmar hyperkeratosis was observed in one subject 
in each group (p>0.1).
A  significant  difference  was  found  in  the  occur-
rence of skin-pigmentation, location and severity 
of pigmentations between the two groups (OR=2.4, 
p<0.007). Concurrent pigmentation in limbs, trunk, 
and tongue was observed in two of the exposed sub-
jects and nine in the controls. This difference was 
not statistically significant (OR=0.24, p=0.17).
DISCUSSION
Cutaneous abnormalities and lesions are the most 
common outcome and health effects from con-
sumption of drinking-water containing arsenic. 
Typically, the cutaneous abnormalities and lesions 
are diagnosed as keratosis and pigment disorder, 
including hyperpigmentation and hypopigmen-
tation. We studied the effects of chronic exposure 
to arsenic on dermatological lesions, hyperten-
sion and chromosomal abnormalities in a region 
in the northwest of Iran. The findings showed a 
high prevalence of skin disorders in individuals 
who consumed water with high concentrations of 
arsenic. 
The results of the study showed that, in the arsenic-
affected village, 30 (30.6%) subjects had hyperkera-
tosis, and 23 (23%) subjects had hyperpigmenta-
tion. However, in the control village, we found one 
person (0.9%) with keratosis and 10 persons (9.3%) 
with pigmentation. 
A study at Guo in Inner Mongolia found that the 
prevalence of keratosis was higher than pigment 
disorder. There was a clear exposure-response rela-
tionship between the prevalence of pigmented le-
sions and the levels of arsenic (61). 
Mosaferi et al. studied 752 subjects in Kurdistan 
province of Iran in eight villages of Bijar county. 
They found a significant correlation of chronic ar-
senic exposure with hyperkeratosis and hyperpig-
mentation. There was also a significant relationship 
between total lifetime intake of arsenic and kerato-
sis, pigmentation, systolic and diastolic blood pres-
sures, and hair arsenic content (9,62). 
In the study of Tondel in Bangladesh, morbidity 
from skin-lesions included almost one-third of the 
population which is similar to our study (63). 
Cumulative arsenic index (CAI) has been shown to 
be associated with hypertension in a dose-response. 
This index is able to well-reflect the cumulative 
dosage of lifetime exposure to arsenic via drinking-
water in individual subjects. 
The study of Huang further explored the associa-
tion between arsenic methylation capability and 
hypertension risk among residents of arseniasis 
hyper-endemic areas in Taiwan (64). The findings 
suggested that hypertensive subjects had higher 
urinary monomethylarsonic acid (MMAV) percent-
age and lower secondary arsenic methylation index 
(SMI) than subjects without hypertension (64).
Other investigations in Taiwan and Bangladesh 
have shown that subjects with prolonged exposure 
to inorganic arsenic have a significantly higher 
risk of hypertension in a dose-response pattern 
(27,28). 
A cross-sectional study on 8,790 pregnant women 
observed increased systolic blood pressure levels 
with increasing arsenic contents in drinking-water 
(65). Our study has shown that subjects with high 
CAI had higher blood pressure even after stopping 
consumption of contaminated water for five years.
In Iran, the delayed effects of exposure to arsenic 
on health, incomplete monitoring of chemical 
quality, technical limitation for analysis of arsenic, 
the lack of common definitions, poor awareness, 
and reporting in the region are the major problems 
in determining the extent of the arsenic problem 
in drinking-water. It seems, therefore, necessary to 
create a reliable databank and information system Dastgiri S et al. Illnesses from chronic arsenic exposure in Iran
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Table 3. Dermatological lesions and chromosomal abnormalities in Ghopuz and Mayan
Disorder
Ghopuz Mayan Statistical 
significance No. % No.         %
Keratosis
No  68 68.7 105 99.1 OR=34, p<0.001
Yes 31 31.3 1            0.9
Location of keratosis
No keratosis 68 68.7 105 99.1
Hands 1 1 1 0.9 OR=1.1, p>0.10
Feet 21 21.2 0 0 p<0.001
Both hands and feet 9  9.1 0 0 p<0.001
Severity of keratosis
No keratosis 68 68.7 105 99.1
Mild 21 21.2 1 0.9 OR=23, p<0.001
Moderate 10 10.1 0 0 p<0.001
Pigmentation
No  77  77 97 90.7
Yes 23  23 10 9.3 OR=2.4, p=0.007
Location of pigmentation
No pigmentation 77  77 97 90.7
Limbs 0 0 1 0.9 p<0.001
Limbs and trunk 21 21 0 0 p<0.001
Limbs, trunk, and tongue 2  2 9 8.4 OR=0.24, p=0.17
Severity of pigmentation
No pigmentation 77 77 97 92.4
Mild 8 8 4 3.8 OR=2.1, p<0.001
Moderate 14 14 4 3.8 OR=3.7, p<0.001
Severe 1 1 0 0 p<0.001
Chromosomal abnormalities
No abnormalities 18 75 18 81.8
p<0.05
21 Trisomy 0 0 2 9.1
Chromatide cleavage 0 0 2 9.1
Endo-reduplication 2 8.3 0 0
Endo-reduplication, gap and 
acentric fragment 1 4.1 0 0
Acentric fragment and 45- (-x  
or -C)/47- chromosomes 3 12.5 0 0
OR=Odds ratio
for chemical quality of drinking-water in some sus-
picious polluted areas in the country.
Our study had some limitations. The physician was 
aware of exposure status. Determination of skin-
manifestation in the exposure group and control 
group was not, therefore, blind. Blood pressure was 
measured once only while it is recommended to re-
peat the measurement 2-3 times for a valid result. 
For calculation of CAI value, it was difficult to ob-
tain and calculate accurate data of water consump-
tion for each individual and the duration of expo-
sure to arsenic. 
In Ghopuz village, an important concern was the 
consumption of contaminated water by livestock 
because of the shortage of safe water in the region. 
Results of a study in Argentina showed that con-
tamination in water supply for livestock may lead 
to contamination of dairy (66). This emphasizes 
the necessity of monitoring the chemical profile of 
water sources in livestock too, even if there is no 
detectable/considerable contamination in water 
supply for humans. Another important issue in 
dealing with arsenic-related problems is public edu-
cation, particularly in the communities with low 
socioeconomic status. Dastgiri S et al. Illnesses from chronic arsenic exposure in Iran
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The study concludes that arsenic exposure is a se-
rious health problem in the region. More studies 
are needed to investigate the long-term effects and 
dose-response relationship of arsenic in the region 
and similar areas. Wide-ranging monitoring pro-
grammes of drinking-water sources should be im-
plemented by public-health authorities. 
Geo-coding of contaminated areas (using the Geo-
graphical Information System) and monitoring the 
contamination rate of soil and agricultural prod-
ucts in arsenic-contaminated areas may also help 
prevent further similar problems in the region.
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